MANGALAM Intraday Analysis...

MANGALAM Share Price

Open 169.45 Change Price %
High 173.75 1 Day -0.25 -0.15
Low 167.10 1 Week -2.55 -1.50
Close 168.00 1 Month -3.20 -1.87
Volume 71502 1 Year -6.25 -3.59
52 Week High 214.90
52 Week Low 122.60
MANGALAM Important Levels
Resistance 2 174.16
Resistance 1 171.62
Pivot 169.62
Support 1 164.38
Support 2 161.84
NSE INDIA Most Active Stocks
JPASSOCIAT 23.05 0.00%
SINTEX 37.85 7.83%
UNITECH 8.55 1.79%
HUDCO 90.25 3.50%
RENUKA 16.55 10.33%
GVKPIL 8.35 1.21%
STRTECH 207.20 19.98%
FEDERALBNK 119.00 3.03%
SUZLON 18.50 0.27%
AXISBANK 540.00 3.81%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.15 50.00%
REIAGROLTD 0.25 25.00%
SPYL 0.30 20.00%
STRTECH 207.20 19.98%
SEINV 220.50 19.22%
COUNCODOS 4.25 16.44%
VASWANI 12.85 15.25%
ALICON 609.60 14.11%
ARCOTECH 84.60 14.02%
GRAPHITE 199.90 13.00%
More..
NSE INDIA Top Losers Stocks
NOESISIND 0.10 -33.33%
SPCENET 0.15 -25.00%
NAKODA 0.30 -14.29%
NUTEK 0.90 -10.00%
WABAG 602.95 -9.78%
ZENITHBIR 0.50 -9.09%
SUTLEJTEX 896.00 -8.17%
MASTEK 330.45 -8.06%
MENONBE 87.85 -7.53%
PRADIP 2.05 -6.82%
More..

Mangalam Drugs And Organics Limited (NSE: MANGALAM)

MANGALAM Technical Analysis 1.5
As on 20th Jul 2017 MANGALAM Share Price closed @ 168.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 159.40 & Sell for SHORT-TERM with Stoploss of 173.57 we also expect STOCK to react on Following IMPORTANT LEVELS.
MANGALAM Target for July
1st Target up-side 170.89
2nd Target up-side 179.25
3rd Target up-side 187.62
1st Target down-side 147.01
2nd Target down-side 138.65
3rd Target down-side 130.28
MANGALAM Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 48.70 Sideways
MFI (14) MFI is 73.23 Sideways
CCI (20) CCI is 52.16 Sideways
WILLIAM %R (14) William %R is -50.13 Sideways
ADX (14) ADX is 15.31 Range Bound
PSAR Stoploss For Long Buy 165.10
10 Day Avg Volume Traded 14.85 % More then 10 Day Average Volume
MANGALAM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
MANGALAM Address
MANGALAM
N/A
MANGALAM Latest News
Mangalam Drugs And Organics Limited   Moneycontrol.com   - 19th Mar 15
Clarification sought from Mangalam Drugs & Organics Ltd   Hindu Business Line   - 19th Mar 15
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011   Hindu Business Line   - 17th Feb 15
Mangalam Drugs' director Rajendra Prasad Mimani resigns   Moneycontrol.com   - 03rd Feb 15
They lied to me for 15 years of my life, says asbestosis-afflicted labourer   Mid-Day   - 21st Jul 14
Fire stops work at Mangalam Organics plant in Maharastra   Business Standard   - 07th Feb 14
CRISIL ratings for Indian debt instruments-Feb 4   Reuters   - 04th Feb 14
Dujodwala Products changes its name to Mangalam Organics   Moneycontrol.com   - 05th Nov 13
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011   Hindu Business Line   - 09th Apr 12
Indian takeovers abroad   The Economist   - 01st Mar 12
Interactive Technical Analysis Chart Mangalam Drugs And Organics Limited ( MANGALAM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Mangalam Drugs And Organics Limited
MANGALAM Business Profile
Mangalam Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 5.57 crore.The company has reported a standalone sales of Rs 28.21 crore and a Net Loss of Rs 0.97 crore for the quarter ended Sep 2013.The company management includes Govardhan M Dhoot - Chairman, Subhash C Khattar - Ind. Non-Executive Director, Rajendraprasad Mimani - Ind. Non-Executive Director. It is listed on the BSE with a BSE Code of 532637 and the NSE with an NSE Code of MANGALAM.Its Registered office is at No 292, Princess Street, 2nd Floor, Near Flyover,,Marine Lines Mumbai,Maharashtra - 400002.Their Registrars are Link Intime India Pvt. Ltd.